Accolade Inc. Stock
€6.15
Your prediction

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Accolade Inc.
sharewise wants to provide you with the best news and tools for Accolade Inc., so we directly link to the best financial data sources.
Financials
News

Accolade Inc Stock: $621M Transcarent Buyout Sends Shares Soaring
Accolade Inc, a health technology company with a $572 million market capitalization, has announced its pending acquisition by Transcarent in a cash deal valued at $621 million. The transaction

Accolade Inc Stock: Transcarent Acquisition Values Company at $621M
Accolade Inc is set to undergo a significant transformation following Transcarent's announcement to acquire the healthcare technology company for $621 million. The deal, which values Accolade shares